Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Disulfides × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 4 Gliosarcoma 4 Glioblastoma 4 Brain Neoplasms 3 Ovarian Neoplasms 2 Oligodendroglioma 2 Breast Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Soft Tissue Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Pharyngeal Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 2 1 Neoplasms, Mesothelial 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Liposarcoma 1 Leiomyosarcoma 1 Hemangiosarcoma 1 Glioma 1

Interventions

Doxorubicin 22 Radiotherapy 12 Ifosfamide 11 Trabectedin 10 pazopanib 5 Gemcitabine 5 ribociclib 4 pembrolizumab 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 palbociclib 3 eribulin 3 X-Rays 3 Imatinib Mesylate 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 romidepsin 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡